Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ClinicalTrials.gov |
Last refreshed on:
|
19 February 2015 |
Main ID: |
NCT00780728 |
Date of registration:
|
27/10/2008 |
Prospective Registration:
|
Yes |
Primary sponsor: |
|
Public title:
|
Study Evaluating the Addition of Sildenafil to Bosentan Therapy in Pulmonary Arterial Hypertension
|
Scientific title:
|
Addition of Sildenafil to Bosentan Monotherapy in Patients With Pulmonary Arterial Hypertension (PAH) |
Date of first enrolment:
|
December 2008 |
Target sample size:
|
|
Recruitment status: |
Withdrawn |
URL:
|
http://clinicaltrials.gov/show/NCT00780728 |
Study type:
|
Interventional |
Study design:
|
N/A
|
Phase:
|
Phase 3
|
|
Countries of recruitment
|
Canada
| | | | | | | |
Key inclusion & exclusion criteria
|
Inclusion & Exclusion Criteria
Age minimum:
18 Years
Age maximum:
N/A
Gender:
Both
|
Health Condition(s) or Problem(s) studied
|
Hypertension, Pulmonary
|
Intervention(s)
|
Drug: Sildenafil
|
Source(s) of Monetary Support
|
Please refer to primary and secondary sponsors
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
|
URL:
|
|
|
|